These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37251370)

  • 1. Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma.
    Zhang D; Jiang Z; Hu J; Sun X; Zheng Y; Shen Y
    Front Immunol; 2023; 14():1117585. PubMed ID: 37251370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of RNMT as an immunotherapeutic and prognostic biomarker: From pan-cancer analysis to lung squamous cell carcinoma validation.
    Huang S; Tan C; Zheng J; Huang Z; Li Z; Lv Z; Chen W; Chen M; Yuan X; Chen C; Yan Q
    Immunobiology; 2024 Jul; 229(5):152836. PubMed ID: 39018675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers.
    Boufraqech M; Zhang L; Nilubol N; Sadowski SM; Kotian S; Quezado M; Kebebew E
    Clin Cancer Res; 2016 Sep; 22(17):4491-504. PubMed ID: 27029493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression.
    Yang Z; Yang X; Xu S; Jin P; Li X; Wei X; Liu D; Huang K; Long S; Wang Y; Sun C; Chen G; Hu J; Meng L; Ma D; Gao Q
    Mol Cancer; 2017 Oct; 16(1):163. PubMed ID: 29041931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive role of E2F6 in cancer prognosis and responses of immunotherapy.
    Gong C; Tu Z; Long X; Liu X; Liu F; Liu J; Zhu X; Li J; Huang K
    Int Immunopharmacol; 2024 Jan; 127():111302. PubMed ID: 38071912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer.
    Zhao R; Chen S; Cui W; Xie C; Zhang A; Yang L; Dong H
    Front Immunol; 2023; 14():1232047. PubMed ID: 37936713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors.
    Zeng Y; Li N; Zheng Z; Chen R; Liu W; Zhu J; Zeng M; Cheng J; Peng M; Hong C
    Int J Gen Med; 2021; 14():5415-5429. PubMed ID: 34539183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.
    Cui Z; Zou F; Wang R; Wang L; Cheng F; Wang L; Pan R; Guan X; Zheng N; Wang W
    World J Surg Oncol; 2023 Sep; 21(1):309. PubMed ID: 37759234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Pan-cancer Analysis of CMPK2 as Biomarker and Prognostic Indicator for Immunotherapy.
    Luo J; Zhang Q; Wang S; Zheng L; Liu J; Zhang Y; Wang Y; Wang R; Xiao Z; Li Z
    Curr Cancer Drug Targets; 2024 Mar; ():. PubMed ID: 38486392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNAI2 promotes the malignant transformation of oral leukoplakia by modulating p-EMT.
    Shang Q; Peng J; Jiang Y; Qing M; Zhou Y; Xu H; Chen Q
    Oral Dis; 2023 Nov; 29(8):3232-3242. PubMed ID: 35894087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of
    Li JW; Deng QM; Zhu JL; Min W; Hu XY; Yu Chen H; Luo Z; Lin LL; Wei XL; Zhang YQ; Lou KL; Gao YY; Zhang GJ; Bai JW
    MedComm (2020); 2023 Dec; 4(6):e403. PubMed ID: 37881785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer.
    Peng J; Li P; Li Y; Quan J; Yao Y; Duan J; Liu X; Li H; Yuan D; Wang X
    Sci Rep; 2023 Oct; 13(1):17399. PubMed ID: 37833332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD112 is an epithelial-to-mesenchymal transition-related and immunological biomarker in pan-cancer.
    Zhang H; Lu J; Dong Q; Wang G; Wang X
    Transl Cancer Res; 2024 May; 13(5):2387-2407. PubMed ID: 38881943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer.
    Zhang S; Qin O; Xu H; Wu S; Huang W; Song H
    Aging (Albany NY); 2023 Dec; 15(24):14845-14863. PubMed ID: 38112634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies.
    Sun A; Cai F; Xiong Q; Xie T; Li X; Xie Y; Luo R; Hu W; Zhong F; Wang S
    Front Mol Biosci; 2023; 10():1277830. PubMed ID: 37942289
    [No Abstract]   [Full Text] [Related]  

  • 16. Unveiling the Impact of MRC1 on Immune Infiltration and Patient's Prognosis: A Pan-Cancer Analysis Based on Single-Cell and Bulk Sequencing.
    Wu Z; Huang C
    Int J Gen Med; 2024; 17():2575-2592. PubMed ID: 38855425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction.
    Zeng J; Li X; Zhang Y; Zhang B; Wang H; Bao S; Zu L; Zhang H; Cheng Y; Tang Q; Xu X; Xu S; Song Z
    Aging (Albany NY); 2024 May; 16(9):7647-7667. PubMed ID: 38728250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Hydroxyphenylpyruvate Dioxygenase-Like predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis.
    Li H; Liu J; Wang S; Xu Y; Tang Q; Ying G
    Aging (Albany NY); 2024 Mar; 16(5):4327-4347. PubMed ID: 38451188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer Analysis Identifies AIMP2 as a Potential Biomarker for Breast Cancer.
    Qiu J; Zhou T; Wang D; Hong W; Qian D; Meng X; Liu X
    Curr Genomics; 2023 Dec; 24(5):307-329. PubMed ID: 38235352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the prognostic, diagnostic, and immunological roles of DSCC1 and its genomic alteration and instability in human cancers.
    Liu H; Cui Z; Wang R; Wang L; Wang L; Cheng F; Pan R; Yang X
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):202-211. PubMed ID: 38678604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.